Background Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease
with considerable morbidity. Heterogeneity in epidemiologic studies means the full impact of …

As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a
need to coordinate data on incidence and mortality globally. This study aims to …

Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

There are limited epidemiologic studies describing the global burden and geographic
heterogeneity of interstitial lung disease (ILD) subtypes. We found that among seventeen …

Sarcoidosis epidemiology: recent estimates of incidence, pre... : Current Opinion in Pulmonary
Medicine Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors …

This document is an international evidence-based guideline on the diagnosis and
management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American …

The objective of the study was to estimate the prevalence and incidence of interstitial lung
diseases (ILDs) in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia
of unknown aetiology. It is a rare disease, and its incidence and prevalence are not clear …

Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that occurs
in adults and has a poor prognosis. Its epidemiology has been difficult to study because of …

Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations
that commonly affects the pulmonary system and other organs including the eyes, skin, liver …